American Financial Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on November 8, 2025

November 8, 2025

New leadership at the International Sustainable Forestry Coalition

EIN Presswire

November 8, 2025

Strategic3C Manages $85 Million Capital Campaign While Launching Game-Changing Platform fetchfund

EIN Presswire

November 8, 2025

BusinessRocket Cuts LLC Costs by 25% to Boost Startups and Empower Entrepreneurs

EIN Presswire

November 8, 2025

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

GlobeNewswire

November 8, 2025

CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire

November 8, 2025

ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR

GlobeNewswire

November 8, 2025

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

GlobeNewswire

November 8, 2025

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire

November 8, 2025

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

GlobeNewswire

November 8, 2025

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases

GlobeNewswire

November 8, 2025

Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

GlobeNewswire

November 8, 2025

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

GlobeNewswire

November 8, 2025

Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet

GlobeNewswire

November 8, 2025

Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

GlobeNewswire

November 8, 2025

LANTHEUS CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds Lantheus Stockholders to Contact the Firm Before November 10th Regarding Their Rights

GlobeNewswire

November 8, 2025

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

GlobeNewswire

November 8, 2025

Synopsys, Inc. (SNPS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - RGRD Law

GlobeNewswire

November 8, 2025

ASIMOV Platform 25.0 Launches: Turning Web Data Into Verifiable Intelligence

EIN Presswire

November 8, 2025

OMS Energy, 수익성 높은 파이프라인 석유 점검 및 유지 보수 시장 진출 위해 AI+로봇 연구 개발 착수

GlobeNewswire

November 8, 2025

OMSエナジー (OMS Energy)、高収益のパイプライン石油検査・保守市場への参入に向けAI+ロボティクスの研究開発を開始

GlobeNewswire